Epigenetic Mechanisms in Cancer, Volume 3

1. Epigenetic Regulation in Pediatric Leukemia
P. Pallavi Madhusoodhan, William L. Carroll and Teena Bhatla

2. Role of Epigenetics in testicular cancer
Emmanuelle Martinot, Marine Baptissart, Lauriane Sédes, and David H. Volle

3. Changes in the epigenetic landscape of prostate cancer
Brenda C. Salumbides and Shabana Shabbeer Meyering

4. Epigenetic health disparities and colon cancer
Sabita Saldanha

5. Genetic and epigenetic modifications in pancreatic cancer
Sanjay Kumar, Rajesh Singh, Manoj Mishra

6. Epigenetics of Breast Cancer
Jovana Klajic, Vessela Kristensen

7. Epigenetic Modulations in Ovarian Cancer
Shriti Singh, Manoj Kumar Mishra and Rajesh Singh

8. Epigenetic Epidemiology for Cancer Risk
Timothy M. Barrow

9. Epigenetic biomarkers in cancer epidemiology
Tomi Akinyemiju

10. Epigenetic biomarkers and racial differences in cancer
Bernard Kwabi-Addo

11. Epigenetic predictive biomarkers
Barbara Pasculli, Raffaela Barbano, Paola Parrella

12. Epigenetic signatures in the diagnosis and prognosis of cancer
Angela Lopomo, Fabio Coppede

13. Future Challenges and Prospects for the role of epigenetic mechanism in cancer management
Sabita Saldanha

Epigenetic Mechanisms in Cancer provides a comprehensive analysis of epigenetic signatures that govern disease development, progression and metastasis. Epigenetic signatures dictating tumor etiologies present an opportunity for biomarker identification which has broad potential for improving diagnosis, prognosis, prediction, and risk assessment.  This volumes offers a unique evaluation of signature differences in childhood, sex-specific and race-specific cancers, and in doing so broadly illuminates the scope of epigenetic biomarkers in clinical environments. Chapters detail the major epigenetic process in humans consisting of DNA methylation, histone modifications and microRNAs (miRNAs) involved in the initiation, progression and metastasis of tumors. Also delineated are recent technologies such as next generation sequencing that are used to identify epigenetic profiles (primarily methylation analysis) in samples (normal, benign and cancerous) and which are highly important to the analysis of epigenetic outcomes.

• Offers broad coverage that is applicable to audiences in various area of cancer research - population studies, diagnostics, prognosis, prediction, therapy, risk, etc.
• Provides critical review analysis of the topics that will clarify and delineate the potential roles of epigenetic signatures in cancer management
• Covers basic, as well as, clinical areas of epigenetic mechanisms in tumorigenesis
• Features contributions by leading experts in the field
• Provides comprehensive coverage of current epigenetic signatures involved in the etiology of various cancers and miRNAs

Researchers, early clinicians and advanced students investigating cancer at the genetic level